CareDx, Inc (CDNA)
$63.67+2.35%Close
BUYBULL · day 94
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.3B
- Beta
- 2.38
- P/E (TTM)
- 29.64
- Short % float
- 13.37%
- Days to cover
- 4.6
- SI change
- +4.6%
- 1W
- -5.18%
- 1M
- +27.29%
- vs SPY 1W
- -6.34%
- vs SPY 1M
- +24.30%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$57.4BBULLQ 30$400.65+2.54%
- QGENBUYQiagen N.V.$9.4BRECOVERYQ 16$45.65+1.91%
- BLLNSELLBillionToOne, Inc.$4.6BCRISISQ -7$99.94+2.81%
- VCYTBUYVeracyte, Inc.$3.6BBEARQ 15$44.65+3.74%
- WGSSELLGeneDx Holdings Corp.$2.1BCRISISQ -3$71.52-0.59%
- FLGTBUYFulgent Genetics, Inc.$584MRECOVERYQ 13$20.58+4.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on CDNA?
- LOPJLB’s latest quantitative signal on CareDx, Inc (CDNA) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CDNA in?
- CareDx, Inc (CDNA) is currently classified in the BULL HMM market regime on LOPJLB.
- What does CareDx, Inc (CDNA) do?
- CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employi…